PHARMACOLOGICAL TREATMENT AND DRUG INTERACTIONS IN PATIENTS WITH ABDOMINAL AORTIC ANEURYSM

Abstract

The abdominal aortic aneurysm occurs when there is an abnormal and irreversible dilation of the artery, greater than 50% of the size expected for the vessel and it is associated with a mortality rate of 80 to 90%.The control of the main risk factors such as hypertension, dyslipidemia, smoking and thrombotic diseases in small aneurysms is done by several drugs that prevent the development of aneurysm and rupture, however, the use of various medications associated with significant drug interactions can initiate and crucial knowledge about these. Currently, there are few data in the literature about the treatment and drug interactions in patients with AAA, and the purpose of this review is to describe pharmacotherapy and the interactions drugs in patients with AAA.